SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)
CUSIP: P8696W104
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Shares, par value US$0.001 per share
- Shares outstanding
- 71,872,133
- Total 13F shares
- 8,982,045
- Share change
- -1,311,686
- Total reported value
- $224,989,943
- Price per share
- $6.47
- Number of holders
- 8
- Value change
- -$843,805
- Number of buys
- 3
- Number of sells
- 1
Quarterly Holders Quick Answers
What is CUSIP P8696W104?
CUSIP P8696W104 identifies SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP P8696W104:
Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
3.8%
|
2,718,735
|
$333,996,595 | — | 30 Jun 2025 | |
| Vivo Capital IX, LLC |
13D/G
|
— |
6.3%
|
4,539,456
|
$293,522,587 | $0 | 17 Mar 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
8.2%
|
5,903,000
|
$38,192,410 | — | 30 Jun 2025 | |
| Neumann Advisory Hong Kong Ltd |
13F
|
Company |
0.44%
|
315,586
|
$2,042,000 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.8%
|
1,312,520
|
$849,201 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
16,851
|
$109,026 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
16,430
|
$106,302 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
8,344
|
$53,985 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,213
|
$14,318 | — | 30 Jun 2025 | |
| Horizon Investments, LLC |
13F
|
Company |
0%
|
52
|
$336 | — | 30 Jun 2025 | |
| 1Globe Capital LLC |
13D/G
|
— |
32%
|
18,515,315
|
— | $0 | 07 Jul 2025 | |
| Yin Weidong |
13D/G
|
Weidong Yin |
8.8%
|
6,359,500
|
— | $0 | 10 Jul 2025 | |
| Advantech Capital L.P. |
13D/G
|
— |
8.1%
|
5,851,423
|
— | $0 | 08 Jul 2025 | |
| Vivo Capital VIII, LLC |
13D/G
|
Vivo Capital IX, LLC |
6.3%
|
4,541,764
|
— | $0 | 11 Jul 2025 |
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q3 2025
As of 30 Sep 2025,
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,982,045 shares.
The largest 8 holders included
Vivo Capital, LLC, ORBIMED ADVISORS LLC, Neumann Advisory Hong Kong Ltd, WELLS FARGO & COMPANY/MN, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MORGAN STANLEY, UBS Group AG, and Horizon Investments, LLC.
This page lists
8
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
9
Q3 2025 holders
8
Holder diff
-1
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.